Clinical Trial Update: OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine

View source ↗

Summary

A completed clinical trial studying how the OPRM1 A118G genetic variant influences alcohol response and striatal dopamine signaling in alcoholism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism | Status: COMPLETED